AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2018
Jun 1, 2018
32566_dirs_2018-06-01_72510cab-394a-4c7f-acd1-3f85dce18522.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2018-05-30
Reporting Person: LANGER DENNIS (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-05-30 | Common Stock | M | 10000 | $24.39 | Acquired | 49743 | Direct |
| 2018-05-30 | Common Stock | S | 10000 | $37.9245 | Disposed | 39743 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-05-30 | Non-Qualified Stock Option (right to buy) | $24.39 | M | 10000 | Disposed | 2018-11-13 | Common Stock (10000) | Direct |
Footnotes
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.
More from MYRIAD GENETICS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 2